U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06934239) titled 'Impact of Artificial Intelligence on Breast Cancer Screening' on April 11.
Brief Summary: The goal of this clinical trial is to compare patient-centered outcomes when 3D screening mammograms are interpreted with versus without a leading FDA-cleared AI decision-support tool in real-world U.S. settings and to assess patient's perspectives on AI in medicine.
The main questions it aims to answer are:
1. Will AI use be associated with an increase in cancer detection and an initially higher recall rate as radiologists start using AI, followed by a recall rate comparable to that without AI (no more than 1.5 percentage-points higher) aft...